ELOXX PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $47.50 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2017-10-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-10-13
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$2.50K.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $50.00K.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $47.50K.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $0.00.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$259.59K, a 140.13% decline from fiscal 2014.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $646.94K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | -$2.50K derived: sum of 2 quarters · filed 2017-10-13 | -$2.50K derived: sum of 3 quarters · filed 2017-10-13 | $47.50K 10-K · filed 2017-10-13 |
| 2017-03-31 | -$2.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-22 | -$2.50K derived: sum of 2 quarters · filed 2017-05-22 | $47.50K 10-Q · filed 2017-05-22 | $47.50K derived: sum of 4 quarters · filed 2017-10-13 |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | $50.00K 10-Q · filed 2017-02-10 | $50.00K derived: sum of 3 quarters · filed 2017-10-13 | $50.00K derived: sum of 4 quarters · filed 2017-10-13 |
| 2016-09-30 | $50.00K 10-Q · filed 2016-11-14 | $50.00K derived: sum of 2 quarters · filed 2017-10-13 | $50.00K derived: sum of 3 quarters · filed 2017-10-13 | $50.00K derived: sum of 4 quarters · filed 2017-10-13 |
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $0.00 derived: sum of 2 quarters · filed 2017-10-13 | $0.00 derived: sum of 3 quarters · filed 2017-10-13 | $0.00 10-K · filed 2017-10-13 |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-22 | $0.00 derived: sum of 2 quarters · filed 2017-05-22 | $0.00 10-Q · filed 2017-05-22 | $457.75K derived: sum of 4 quarters · filed 2017-10-13 |
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | $0.00 10-Q · filed 2017-02-10 | $457.75K derived: sum of 3 quarters · filed 2017-10-13 | $271.80K derived: sum of 4 quarters · filed 2017-10-13 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $457.75K derived: sum of 2 quarters · filed 2017-10-13 | $271.80K derived: sum of 3 quarters · filed 2017-10-13 | $75.22K derived: sum of 4 quarters · filed 2017-10-13 |
| 2015-06-30 | $457.75K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $271.80K derived: sum of 2 quarters · filed 2017-10-13 | $75.22K derived: sum of 3 quarters · filed 2017-10-13 | -$259.59K 10-K · filed 2017-10-13 |
| 2015-03-31 | -$185.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | -$382.54K derived: sum of 2 quarters · filed 2016-05-12 | -$717.34K 10-Q · filed 2016-05-12 | $339.23K derived: sum of 4 quarters · filed 2016-10-13 |
| 2014-12-31 | -$196.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | -$531.38K 10-Q · filed 2016-02-16 | $525.19K derived: sum of 3 quarters · filed 2016-10-13 | $368.78K derived: sum of 4 quarters · filed 2016-10-13 |
| 2014-09-30 | -$334.80K 10-Q · filed 2015-11-16 | $721.77K derived: sum of 2 quarters · filed 2016-10-13 | $565.36K derived: sum of 3 quarters · filed 2016-10-13 | |
| 2014-06-30 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | $900.17K derived: sum of 2 quarters · filed 2016-10-13 | $646.94K 10-K · filed 2016-10-13 | |
| 2014-03-31 | -$156.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | -$409.64K 10-Q · filed 2015-05-14 | ||
| 2013-12-31 | -$253.23K 10-Q · filed 2015-02-17 | |||
| 2013-06-30 | -$529.04K 10-K · filed 2015-10-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |